🔎 Trials Near Me

ホーム › 心臓疾患 › オハイオ

オハイオにおける心臓疾患の臨床試験

オハイオ内の拠点で、心臓疾患に関する19件の研究が参加者を募集しています。

オハイオ内の都市

公式研究テキスト(英語)

ELEVATE-HFpEF Clinical Study

  • The Ohio State University Wexner Medical Center, Columbus
  • Mount Carmel East, Columbus
被験者募集中
40歳以上 · 全性別 · 2026/10/02更新 · NCT06678841

Transition to KPL-387 Monotherapy Dosing & Administration Study

  • Investigational Site 009, Cincinnati
  • Investigational Site 040, Cleveland
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/30更新 · NCT07288216

Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)

  • The Ohio State University Wexner Medical Center, Columbus
被験者募集中
18歳〜85歳 · 全性別 · 2026/09/29更新 · NCT07585968

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

  • The Christ Hospital, Cincinnati
  • University Hospitals Cleveland Medical Center, Cleveland
  • The Ohio State University Wexner Medical Center, Columbus
  • 他1件
被験者募集中
18歳以上 · 全性別 · 2026/09/15更新 · NCT03242642

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

  • The Christ Hospital - Cincinnati, Cincinnati
  • Cleveland Clinic, Cleveland
被験者募集中
18歳〜100歳 · 全性別 · 2026/09/09更新 · NCT06310031

Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)

  • Cleveland Clinic Foundation, Cleveland
被験者募集中
18歳〜85歳 · 全性別 · 2026/09/03更新 · NCT06703489

Clinical Course Of Disease In Participants With FA-CM

  • Cincinnati Children's Hospital, Cincinnati
被験者募集中観察研究
6歳以上 · 全性別 · 2026/09/02更新 · NCT06865482

Abbott Structural Heart Device Registry

  • The Cleveland Clinic Foundation, Cleveland
被験者募集中観察研究
全年齢 · 全性別 · 2026/09/01更新 · NCT06590467

Randomization of Single vs Multiple Arterial Grafts

  • Cleveland Clinic Foundation, Cleveland
被験者募集中
18歳〜70歳 · 全性別 · 2026/08/20更新 · NCT03217006

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  • Cleveland Clinic, Cleveland
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/08/04更新 · NCT06563895

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

  • The Christ Hospital- Cincinnati, Cincinnati
  • University of Cincinnati, Cincinnati
  • University Hospital (Cleveland), Cleveland
被験者募集中
18歳以上 · 全性別 · 2026/06/29更新 · NCT05934487

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

  • Christ Hospital, Cincinnati
  • The Cleveland Clinic Foundation, Cleveland
被験者募集中
18歳以上 · 全性別 · 2026/06/10更新 · NCT06526195

Pathways to Prevention Food-is-Medicine Trial

  • Nationwide Children's Hospital, Columbus
被験者募集中健康なボランティア歓迎
6歳以上 · 全性別 · 2026/05/15更新 · NCT07380243

Sternal Plating High Risk

  • University Hospitals, Cleveland
被験者募集中
18歳〜89歳 · 全性別 · 2026/04/30更新 · NCT06660186

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

  • Lindner Research Center at the Christ Hospital, Cincinnati
  • Cleveland Clinic, Cleveland
  • The Ohio State University, Columbus
  • 他1件
被験者募集中
18歳以上 · 全性別 · 2026/04/13更新 · NCT03142152

Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

  • Cleveland Clinic Foundation, Cleveland
  • Ohio State University, Columbus
  • Genesis Healthcare System, Zanesville
被験者募集中
18歳以上 · 女性 · 2026/04/01更新 · NCT04124120

Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts

  • Nationwide Children's Hospital, Columbus
被験者募集中第2相
全年齢 · 全性別 · 2025/06/27更新 · NCT04467671

IPSC Repository of Pediatric Cardiovascular Disease

  • Nationwide Children's Hospital, Columbus
被験者募集中観察研究健康なボランティア歓迎
全年齢 · 全性別 · 2025/02/25更新 · NCT05550324

PARTNER 3 Trial - Aortic Valve-in-Valve

  • The Christ Hospital, Cincinnati
  • The Cleveland Clinic Foundation, Cleveland
被験者募集中
全年齢 · 全性別 · 2024/05/10更新 · NCT03003299

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。